Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy - Wikidata - awgldk - TriplyDB

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

http://www.wikidata.org/entity/Q37127423

about

Surgical and molecular pathology of pancreatic neoplasms Biomarkers and Targeted Therapy in Pancreatic Cancer Genetics and biology of pancreatic ductal adenocarcinoma Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles Cancer heterogeneity--a multifaceted view The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Somatic mutations in exocrine pancreatic tumors: association with patient survival New challenges in perioperative management of pancreatic cancer Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome Mechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cells Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts EGF receptor is required for KRAS-induced pancreatic tumorigenesis Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity.Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma.Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions.Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors Transcriptional dissection of pancreatic tumors engrafted in mice.Pancreatic biomarkers: could they be the answer?Personalising pancreas cancer treatment: When tissue is the issue.Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature.Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.

P2860

Q26748615-4D558359-C900-4D40-B5EB-83658F4425D9 Q26752755-83A26710-8AF7-4DDF-9ADB-300F50B7C77E Q26765438-6A42B8C6-C6A3-4286-95B2-6FFE47B8F4FA Q26780372-D8F1C84A-CDFA-4348-847D-D7328A8945EA Q26799714-D1B2BF57-30D3-47DE-BDB5-DA10587DBA4C Q26801410-894F091C-154E-411D-A5EE-58BE0601E75F Q26828959-80BEA784-E621-42AF-8524-986BDE2E4AE9 Q26829228-12BD9F2E-911C-46C5-91A8-ECD510BD9DD4 Q27005952-76C716FC-98B2-44F5-99E0-5633A2110170 Q27307642-8D449AF1-0C5E-4B57-BAEE-FDBFD6150045 Q27852155-0A54B28A-F4B2-48E7-ACEC-467440558F5A Q28082422-1790F93C-408A-4CD0-A4AC-4FD16C85E830 Q28273187-4F181006-D114-4911-9634-8391273BD123 Q28485201-22DC7C12-07DD-496C-B108-6E6492EA6A86 Q28486199-14125091-2426-4254-93BC-9A49AEBB3D6E Q28534130-6E11F1C8-BF22-40DA-92EB-894262A29C45 Q28584901-34F3E6AD-3C49-474D-AEBE-B72136EB39D9 Q30241331-CDF69A3D-8B37-4E9E-B0A7-A2AD18B1CF86 Q30384798-D95E509E-EA97-44A1-9D91-62B343B24307 Q30409158-E46F8313-9C22-429C-8186-F64B1DF45281 Q30472055-88C30FE7-B52D-4E85-8C8D-2D29C39C6F23 Q30528894-8B902ABD-399F-4C2A-A889-9FD52024FF85 Q30754497-5A7FB33D-14F4-46A8-BE4E-AA0B21E267B6 Q30919257-72F9CFED-8A1F-4C31-9820-DF0A79D400AF Q30992577-F6644DB8-6DFD-4CF1-94F0-A6F6D18B30D6 Q33635144-54714C61-7863-4D0B-951E-E4DB6FC0333D Q33754779-72A6CAF7-257B-470C-84B5-08B99B8C0448 Q33763660-9DDDD668-E37D-4F7E-838D-1F14F69BF6F5 Q33772571-C5F2FCFA-55EA-4326-AB3F-FE423A2CC28A Q33801371-C283E384-325B-4E1D-984D-A056CC4DBD9A Q33801384-666E7619-3BD1-479D-93F1-10AD1F39B494 Q33803923-1D966371-1B0F-457C-94AF-228D931D1DA9 Q33826323-E5B5FACA-91A3-4024-A41F-A59F085A6E1E Q33838679-CCFC68C7-6B30-4988-B123-D9DCC95AE91A Q33895591-2BB9E5D3-2814-4E4A-B0BF-F8283A277C3B Q33913549-9FC0FBCC-3180-469E-AC33-7EEB1A942411 Q33943271-84438904-DEF4-4B4A-913B-4934F44F8FCE Q33989933-785BD125-014B-4CC2-8FCB-14C92FE8A23D Q34003440-599A8B79-D8F6-4BF9-B174-779845A5747C Q34067863-AED3D930-D124-4DFB-A042-DFA70F53B52F

P2860

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

http://www.wikidata.org/entity/Q37127423

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

@en

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

@nl

type

label

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

@en

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

@nl

prefLabel

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

@en

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

@nl

P1433

Q37127423-6F84E6BB-4349-464E-BDDD-CAD90F45CE92

P1476

Q37127423-0726EF1B-A939-499C-9EFB-AF93E8CF6106

P2093

Q37127423-3A1C7604-895B-492A-9F7C-84491B54EDAF

Q37127423-3A5F7DD8-620B-4ACF-9815-7E6E4D40180F

Q37127423-3A661047-A923-4802-BB45-FFE8F41DAA7B

Q37127423-3C092FC6-6299-4669-8E36-4FAEDC324E83

Q37127423-42195193-8921-4399-8B76-B4950F8EC93D

Q37127423-421C900F-551D-44CC-BCCD-DDD5EFF1670A

Q37127423-546CA78D-F10B-47D3-A5EC-C364934AB8BD

Q37127423-6B2117AE-E062-4676-8C96-67376D6612C7

Q37127423-889498B9-DBDE-4AC2-9232-AF1390BAB0A4

Q37127423-8C538D87-04B1-4358-953C-07D4F7EB776F

P2860

Q37127423-062E3EB7-2C74-4198-BCAD-C10385B25DF9

Q37127423-13B6F664-82F7-4481-8CF8-278A0406142F

Q37127423-208CCA22-97A9-4C7E-84B7-2F289F07CDDA

Q37127423-2BA72CD2-DE78-4571-AB1D-F5B239460813

Q37127423-30A67F15-A0E3-4DB3-970C-AADC225E7010

Q37127423-3C8879F6-845F-4F46-B72E-6FB916257995

Q37127423-4C474BBA-9BF6-4154-B4B5-5000EBE7B652

Q37127423-4E281BD5-306E-4E71-A6D4-14478FC5D86E

Q37127423-55647AE7-118D-401F-8C99-26999A6A7334

Q37127423-5CCC0111-23D9-47FB-AABB-E4B0EFF273D4

P2888

Q37127423-101DF655-5888-42D6-AD51-8E633FBB1C61

P304

Q37127423-9F6B2A37-9227-4743-9635-02AE0A78A954

P31

Q37127423-7F5FD598-8800-43AD-B009-C15D1C182FE8

P356

Q37127423-D89507B0-7653-42CD-8ACB-8A9E43A1816C

P407

Q37127423-578E84BB-7513-4E54-AE53-4495BE6B23B6

P433

Q37127423-AFCB485F-1233-49D4-8BA2-D92839476289

P478

Q37127423-72298C98-F73D-430D-9620-B5F509D796B9

P577

Q37127423-66A24AFD-FAB6-4A25-B96E-17764B124A0F

P5875

Q37127423-4A14D98D-55C7-46B6-AAF1-A20961091541

P698

Q37127423-9DC1A164-001A-433E-AD3B-EF28DBF73E2A

P921

Q37127423-EE30F64E-B3D1-474C-8FCD-7B75EC882396

P932

Q37127423-40A15F2E-C2D8-464D-BD57-2511A36B1135

P356

P1433

Nature Medicine

P1476

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

@en

P2093

Adam B Olshen

http://www.w3.org/2001/XMLSchema#string

Andrew H Ko

http://www.w3.org/2001/XMLSchema#string

Anguraj Sadanandam

http://www.w3.org/2001/XMLSchema#string

Douglas Hanahan

http://www.w3.org/2001/XMLSchema#string

Eric A Collisson

http://www.w3.org/2001/XMLSchema#string

Grace E Kim

http://www.w3.org/2001/XMLSchema#string

Heidi S Feiler

http://www.w3.org/2001/XMLSchema#string

Janine Cooc

http://www.w3.org/2001/XMLSchema#string

Jennifer Weinkle

http://www.w3.org/2001/XMLSchema#string

Joe W Gray

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

GATA-6 mediates human bladder smooth muscle differentiation: involvement of a novel enhancer element in regulating alpha-smooth muscle actin gene expression

Significance analysis of microarrays applied to the ionizing radiation response

International network of cancer genome projects.

Cluster analysis and display of genome-wide expression patterns

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

P2888

P304

500-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2344

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50989725

http://www.w3.org/2001/XMLSchema#string

P698

21460848

http://www.w3.org/2001/XMLSchema#string

P921

P932

3755490

http://www.w3.org/2001/XMLSchema#string